These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 17979497)

  • 81. TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes.
    Sakamoto T; Woodcock-Mitchell J; Marutsuka K; Mitchell JJ; Sobel BE; Fujii S
    Am J Physiol; 1999 Jun; 276(6):C1391-7. PubMed ID: 10362602
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and fibrinolysis in renal graft fibrosis.
    Grandaliano G; Di Paolo S; Monno R; Stallone G; Ranieri E; Pontrelli P; Gesualdo L; Schena FP
    Transplantation; 2001 Oct; 72(8):1437-43. PubMed ID: 11685117
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases.
    Ha H; Oh EY; Lee HB
    Nat Rev Nephrol; 2009 Apr; 5(4):203-11. PubMed ID: 19322185
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture.
    Xu Z; Castellino FJ; Ploplis VA
    Blood; 2010 Mar; 115(10):2038-47. PubMed ID: 20009036
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Endothelial H
    Chen X; Wang H; Wu C; Li X; Huang X; Ren Y; Pu Q; Cao Z; Tang X; Ding BS
    Redox Biol; 2024 Apr; 70():103038. PubMed ID: 38266576
    [TBL] [Abstract][Full Text] [Related]  

  • 86. New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury.
    Arteel GE
    J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1(Suppl 1):S54-9. PubMed ID: 18336665
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis.
    Beier JI; Kaiser JP; Guo L; Martínez-Maldonado M; Arteel GE
    Arch Biochem Biophys; 2011 Jun; 510(1):19-26. PubMed ID: 21501583
    [TBL] [Abstract][Full Text] [Related]  

  • 88. PAI-1 as a target in kidney disease.
    Huang Y; Noble NA
    Curr Drug Targets; 2007 Sep; 8(9):1007-15. PubMed ID: 17896952
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-β/ALK5 inhibitor.
    Park J; Choi J; Cho I; Sheen YY
    Sci Rep; 2022 Sep; 12(1):16104. PubMed ID: 36167880
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Role of plasminogen activator inhibitor-1 in senescence and aging.
    Eren M; Boe AE; Klyachko EA; Vaughan DE
    Semin Thromb Hemost; 2014 Sep; 40(6):645-51. PubMed ID: 25173500
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Plasminogen Activator Inhibitor-1 and Oncogenesis in the Liver Disease.
    Nam DE; Seong HC; Hahn YS
    J Cell Signal; 2021; 2(3):221-227. PubMed ID: 34671766
    [TBL] [Abstract][Full Text] [Related]  

  • 92. PAI-1 Interaction with Sortilin Related Receptor-1 is Required for Lung Fibrosis.
    Sisson TH; Osterholzer JJ; Leung L; Basrur V; Nesvizhskii A; Subbotina N; Warnock M; Torrente D; Virk AQ; Horowitz JC; Migliorini M; Strickland DK; Kim KK; Huang SK; Lawrence DA
    bioRxiv; 2024 Aug; ():. PubMed ID: 39211273
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Challenging delivery of VLHL NS plasminogen activator inhibitor-1 by osmotic pumps in diabetic mouse: A case report.
    Jankun J
    Exp Ther Med; 2012 Oct; 4(4):661-664. PubMed ID: 23170122
    [TBL] [Abstract][Full Text] [Related]  

  • 94. PAI-1 in tissue fibrosis.
    Ghosh AK; Vaughan DE
    J Cell Physiol; 2012 Feb; 227(2):493-507. PubMed ID: 21465481
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.
    Cesari M; Pahor M; Incalzi RA
    Cardiovasc Ther; 2010 Oct; 28(5):e72-91. PubMed ID: 20626406
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Therapeutic potential of an orally effective small molecule inhibitor of plasminogen activator inhibitor for asthma.
    Liu RM; Eldridge S; Watanabe N; Deshane J; Kuo HC; Jiang C; Wang Y; Liu G; Schwiebert L; Miyata T; Thannickal VJ
    Am J Physiol Lung Cell Mol Physiol; 2016 Feb; 310(4):L328-36. PubMed ID: 26702150
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Mechanisms of initiation and progression of intestinal fibrosis in IBD.
    Latella G; Di Gregorio J; Flati V; Rieder F; Lawrance IC
    Scand J Gastroenterol; 2015 Jan; 50(1):53-65. PubMed ID: 25523556
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hypoxia and Foxn1 alter the proteomic signature of dermal fibroblasts to redirect scarless wound healing to scar-forming skin wound healing in Foxn1
    Gawronska-Kozak B; Machcinska-Zielinska S; Walendzik K; Kopcewicz M; Pääkkönen M; Wisniewska J
    BMC Biol; 2024 Sep; 22(1):193. PubMed ID: 39256768
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy: pulmonary and vascular endothelial function-an exploratory analysis.
    van der Schoot GGF; Ormel HL; Westerink NL; Wempe JB; Lefrandt JD; May AM; Vrieling AH; Meijer C; Gietema JA; Walenkamp AME
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17467-17478. PubMed ID: 37889308
    [TBL] [Abstract][Full Text] [Related]  

  • 100. PAI-1 regulates AT2-mediated re-alveolarization and ion permeability.
    Ali G; Zhang M; Chang J; Zhao R; Jin Y; Zhang J; Ji HL
    Stem Cell Res Ther; 2023 Jul; 14(1):185. PubMed ID: 37501095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.